BR9007702A - Metodo de tratamento - Google Patents

Metodo de tratamento

Info

Publication number
BR9007702A
BR9007702A BR909007702A BR9007702A BR9007702A BR 9007702 A BR9007702 A BR 9007702A BR 909007702 A BR909007702 A BR 909007702A BR 9007702 A BR9007702 A BR 9007702A BR 9007702 A BR9007702 A BR 9007702A
Authority
BR
Brazil
Prior art keywords
live virus
subject
neutralizing
antibody
treatment method
Prior art date
Application number
BR909007702A
Other languages
English (en)
Portuguese (pt)
Inventor
Craig E Whitfill
Tommy L Fredericksen
Julius K Tyczkowski
James Paul Thaxton Jr
Original Assignee
Embrex Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Embrex Inc filed Critical Embrex Inc
Priority claimed from PCT/US1990/005581 external-priority patent/WO1991004750A1/en
Publication of BR9007702A publication Critical patent/BR9007702A/pt

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • C07K16/08—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from viruses
    • C07K16/10—RNA viruses
    • C07K16/112—Retroviridae (F), e.g. leukemia viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • C07K16/08—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from viruses
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • C07K16/08—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from viruses
    • C07K16/081—DNA viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/505—Medicinal preparations containing antigens or antibodies comprising antibodies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/525—Virus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/55—Medicinal preparations containing antigens or antibodies characterised by the host/recipient, e.g. newborn with maternal antibodies
    • A61K2039/552—Veterinary vaccine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2720/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsRNA viruses
    • C12N2720/00011—Details
    • C12N2720/10011—Birnaviridae
    • C12N2720/10034—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S435/00—Chemistry: molecular biology and microbiology
    • Y10S435/8215—Microorganisms
    • Y10S435/948—Microorganisms using viruses or cell lines

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Virology (AREA)
  • Immunology (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Biophysics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biochemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Mycology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Microbiology (AREA)
  • Oncology (AREA)
  • Engineering & Computer Science (AREA)
  • Communicable Diseases (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicinal Preparation (AREA)
  • Crystals, And After-Treatments Of Crystals (AREA)
  • Chemical Treatment Of Metals (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
BR909007702A 1989-10-02 1990-10-01 Metodo de tratamento BR9007702A (pt)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US41603589A 1989-10-02 1989-10-02
US48067890A 1990-02-15 1990-02-15
US58685990A 1990-09-24 1990-09-24
PCT/US1990/005581 WO1991004750A1 (en) 1989-10-02 1990-10-01 Method of treatment

Publications (1)

Publication Number Publication Date
BR9007702A true BR9007702A (pt) 1992-08-18

Family

ID=27411077

Family Applications (1)

Application Number Title Priority Date Filing Date
BR909007702A BR9007702A (pt) 1989-10-02 1990-10-01 Metodo de tratamento

Country Status (11)

Country Link
US (4) US5397569A (https=)
EP (2) EP0495008B1 (https=)
AT (2) ATE200735T1 (https=)
AU (2) AU6714290A (https=)
BR (1) BR9007702A (https=)
CA (1) CA2066661C (https=)
DE (2) DE69033728T2 (https=)
DK (2) DK0755684T3 (https=)
ES (2) ES2158200T3 (https=)
IL (1) IL95867A (https=)
WO (1) WO1991004749A1 (https=)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ZA93216B (en) * 1992-01-17 1993-08-18 Solvay Animal Health Inc Vaccine containing acemannan as an adjuvant.
JPH07206705A (ja) * 1993-11-03 1995-08-08 American Cyanamid Co 生インオボ（ｉｎ ｏｖｏ）ワクチン
US5807551A (en) * 1996-04-01 1998-09-15 Iowa State University Research Foundation, Inc. Method to provide artificial passive immunity in birds
ATE272409T1 (de) 1996-09-30 2004-08-15 Univ Arkansas Verfahren zur erzeugung aktiver immunität durch vakzinkonjugate
US6592869B2 (en) 1999-08-24 2003-07-15 Teva Pharmaceutical Industries, Ltd. Vaccine composition and method of using the same
IL148247A0 (en) * 1999-08-24 2002-09-12 Teva Pharma A vaccine composition and method of using the same
US6682754B2 (en) 1999-11-24 2004-01-27 Willmar Poultry Company, Inc. Ovo delivery of an immunogen containing implant
US20030170823A1 (en) * 1999-12-23 2003-09-11 Presnell Scott R. Novel cytokine ZCYTO18
EP1161953A3 (en) * 2000-06-09 2004-02-04 Akzo Nobel N.V. IBDV strain for in OVO administration
ZA200104596B (en) * 2000-06-09 2001-12-06 Akzo Nobel Nv IBDV strain for in ovo administration.
US7037506B2 (en) 2002-03-08 2006-05-02 Schweltzer Chemical Corporation Ltd. Vaccine accelerator factor (VAF) for improvement of vaccinations in poultry
US7029681B2 (en) 2002-03-08 2006-04-18 Schweitzer Chemical Corporation Multiple and multivalent DNA vaccines in ovo
AU2003223344B9 (en) 2002-03-22 2009-07-16 Zymogenetics, Inc. Anti-IL-TIF antibodies and methods of using in inflammation
US6729265B2 (en) * 2002-06-27 2004-05-04 Arkion Life Sciences Llc Supplemented antibody feed to enter the circulating system of newborns
US20080233053A1 (en) * 2005-02-07 2008-09-25 Pharmalight Inc. Method and Device for Ophthalmic Administration of Active Pharmaceutical Ingredients
EP2164511A1 (en) * 2007-05-22 2010-03-24 Baylor College Of Medicine Immune complex vaccination as a strategy to enhance immunity in the elderly and other immune compromised populations
USRE49477E1 (en) 2012-04-20 2023-03-28 Thomas Jefferson University Engineered antibody for inhibition of fibrosis
WO2014110092A1 (en) * 2013-01-08 2014-07-17 Humabs Biomed Sa Methods of generating robust passive and active immune responses
CN103341164B (zh) * 2013-07-19 2015-06-24 天津瑞普生物技术股份有限公司 一种鸡传染性法氏囊病抗原抗体复合物、制剂及制备方法
KR102850522B1 (ko) 2019-09-11 2025-08-26 조에티스 서비시즈 엘엘씨 조류 병원체의 항원을 발현하는 재조합 칠면조 헤르페스바이러스 벡터 및 이의 용도

Family Cites Families (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2518978A (en) * 1946-09-12 1950-08-15 American Cyanamid Co Hog cholera vaccine
DE1041214B (de) * 1957-03-11 1958-10-16 Dr Med Karl Theurer Verfahren zur Herstellung von Impfstoffen gegen Viruserkrankungen
US3846543A (en) * 1963-01-02 1974-11-05 Monsanto Co Process for the separation of virus from non-viral proteins
US3326767A (en) * 1966-03-21 1967-06-20 Abbott Lab Avian leukosis treatment with inactivated rous sarcoma virus
US3651213A (en) * 1969-05-29 1972-03-21 Monsanto Co Method for the immunization of a living animal body against viral disease
US3853467A (en) * 1973-08-15 1974-12-10 Gen Electric Method and apparatus for immunological detection of biological particles
CA1039649A (en) * 1973-08-30 1978-10-03 General Electric Company Method of forming multilayer immunologically complexed films
JPS57136528A (en) * 1981-02-09 1982-08-23 Hayashibara Biochem Lab Inc Preparation of viral vaccine
EP0073856A1 (en) * 1981-08-28 1983-03-16 Gist-Brocades N.V. Infectious-bronchitis vaccines for poultry, combined infectious-bronchitis vaccines, process for preparing such vaccines, process for preventing infectious bronchitis and infectious-bronchitis virus strain
US4458630A (en) * 1982-06-22 1984-07-10 The United States Of America As Represented By The Secretary Of Agriculture Disease control in avian species by embryonal vaccination
US4493825A (en) * 1982-10-05 1985-01-15 Iowa State University Research Foundation Purified and antigenically selective vaccines for domestic animals
US4530831A (en) * 1982-11-02 1985-07-23 Akzo N.V. Infectious Bursal Disease vaccine
US4614793A (en) * 1983-10-14 1986-09-30 Merck & Co., Inc. Hepatitis A--subunit antigen
US4743562A (en) * 1984-08-21 1988-05-10 The Board Of Trustees Of The Leland Stanford Junior University Purified human cytomegalovirus protein
US4824668A (en) * 1987-03-09 1989-04-25 Sterwin Laboratories Inc. Attenuated infectious bursal disease virus strain and vaccine therefrom
US4956452A (en) * 1987-06-14 1990-09-11 The University Of Maryland Monoclonal antibody which neutralizes multiple strains of infectious bursal disease virus
US4867975A (en) * 1988-01-27 1989-09-19 University Of Delaware Live attenuated temperature-sensitive avian infectious bronchitis virus vaccines and preparation and use thereof
US5057314A (en) * 1988-09-30 1991-10-15 Whitfill Craig E Low molecular weight antiviral factors

Also Published As

Publication number Publication date
WO1991004749A1 (en) 1991-04-18
US6299874B1 (en) 2001-10-09
EP0495008B1 (en) 1997-04-02
DE69030383D1 (de) 1997-05-07
ATE200735T1 (de) 2001-05-15
ES2158200T3 (es) 2001-09-01
DE69033728T2 (de) 2001-11-22
DE69033728D1 (de) 2001-05-31
DK0755684T3 (da) 2001-08-20
DK0495008T3 (da) 1997-10-13
US6136319A (en) 2000-10-24
EP0495008A4 (en) 1993-05-05
AU6714290A (en) 1991-04-28
IL95867A (en) 1994-10-07
CA2066661A1 (en) 1991-04-03
AU641958B2 (en) 1993-10-07
US5397569A (en) 1995-03-14
US5871748A (en) 1999-02-16
AU6755990A (en) 1991-04-28
CA2066661C (en) 2001-05-08
EP0495008A1 (en) 1992-07-22
IL95867A0 (https=) 1991-07-18
DE69030383T2 (de) 1997-10-23
EP0755684B1 (en) 2001-04-25
EP0755684A1 (en) 1997-01-29
ATE150976T1 (de) 1997-04-15
ES2102368T3 (es) 1997-08-01

Similar Documents

Publication Publication Date Title
BR9007702A (pt) Metodo de tratamento
ID21338A (id) Metoda untuk menghasilkan kekebalan aktif dengan vaksin gabungan
LU91396I2 (fr) "La combinaison de la protéine L1 recombinante du papillomavirus humain de types 6,11,16 et 18" -Gardasil/Silgard
DK0466037T3 (da) Fremgangsmåde til fremstilling af et gærglucan
DE69133516D1 (de) Behandlung von autoimmunkrankheiten durch orale verabreichung von autoantigenen
YU48250B (sh) Postupak za pripremanje aktivne vakcine protiv lajmske bolesti
EP0716613A4 (en) TREATING A GASTRODUODENAL DISEASE CAUSED BY -i (HELICOBAKTER PYLORI)
MX9202781A (es) Vacuna y metodo de tratamiento para virus de inmunodeficiencia humana.
FI955150L (fi) OspC-antigeenirokotteiden immunogeenisia formulaatioita lyymisairauden ehkäisyyn ja hoitoon ja rekombinanttimenetelmiä antigeenien valmistamiseksi
DE69030099D1 (de) Verfahren zur herstellung von impfstoffen oder toxoiden
DE3889581D1 (de) Monoklonale Antikörper gegen spezifische antigene Regionen des humanen Immundefizienzvirus und Methoden zur Verwendung.
DE69333730D1 (de) Impfstoff, der acemannan als adjuvans enthält
SG46451A1 (en) Detection and treatment of infections with immunoconjugates
ATE142262T1 (de) Gegen das menschliche immunschwäche-virus gerichtetes immunpräparat
NZ235474A (en) Virus capable of inducing infectious bursal disease; assay and vaccine
ATE39055T1 (de) Verfahren zur immunisierung von schweinen gegen die aujeszky-krankheit.
RU93052279A (ru) Способ лечения инфекционных заболеваний
RU96123906A (ru) Способ и вакцина для профилактики и лечения иммунодефицитов, например рака
SU1739559A1 (ru) Штамм вируса aphtae epizooticae типа o, используемый для изготовления диагностических сывороток и антигенных препаратов
Epstein The Vaccine Control of Virus-Induced Cancers
CS578887A1 (en) Inactivated antigen of cattle's mucosal disease's virus
ATE99956T1 (de) Newcastle-krankheitsvirus-impfstoff und methode fuer seine verwendung.
RU93005036A (ru) Способ лечения вируса иммунодефицита человека
HUP9902513A2 (hu) Aktív immunitás létrehozására szolgáló vakcinakonjugátumok
FI972658L (fi) Menetelmä rokotteen valmistamiseksi siipikarjan tarttuvaa bursaalitautia vastaan

Legal Events

Date Code Title Description
EG Technical examination (opinion): publication of technical examination (opinion)
FC Decision: refusal
CKFC Appeal: appeal against refusal
B15W Others matters related to applications: legal action concerning application

Free format text: INPI-52400.004312/05 SECAO JUDICIARIA DA 37A VARA FEDERAL DO RIO DE JANEIRO ACAO ORDINARIA/ PROPRIEDADE INDUSTRIAL NO 2005.51.01.519679-0 NO DE MANDADO: MTL.0037.000341-4/2005 AUTOR: UNIVERSITY OF ARKANSAS REU: INSTITUTO NACIONAL DA PROPRIEDADE INDUSTRIAL - INPI DECISAO: PEDIDO SUB-JUDICE.

B25A Requested transfer of rights approved

Owner name: UNIVERSITY OF ARKANSAS (US)

Free format text: TRANSFERIDO DE: EMBREX, INC.

B15N Others concerning applications: notification of judicial decision

Free format text: INPI-52400.004312/05 SECAO JUDICIARIA DO RIO DO JANEIRO - 13A VARA FEDERAL PROCESSO NO: 2005.51.01.519679-0 RECURSO ESPECIAL NO 1.096.434 RECORRENTE: UNIVERSITY OF ARKANSAS RECORRIDO: INSTITUTO NACIONAL DA PROPRIEDADE INDUSTRIAL - INPI DECISAO: TRANSITO EM JULGADO DO ACORDAO DO SUPERIOR TRIBUNAL DE JUSTICA, QUE DEU PROVIMENTO APENAS EM PARTE AO RECURSO ESPECIAL, MANTENDO, PORTANTO, O ACORDAO DO TRF DA 2A REGIAO, QUE HAVIA NEGADO PROVIMENTO A APELACAO, CONFIRMANDO A SENTENCA QUE HAVIA JULGADO IMPROCEDENTE O PEDIDO AUTORAL.